More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine
Int J Infect Dis
.
2021 Feb:103:402-403.
doi: 10.1016/j.ijid.2020.12.010.
Epub 2020 Dec 9.
Authors
S Verheijen
1
,
M van Luin
2
,
R J Brüggemann
3
,
Q de Mast
3
,
R J Hassing
2
,
D M Burger
3
Affiliations
1
Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: shenna.verheijen@student.ru.nl.
2
Rijnstate Hospital, Arnhem, The Netherlands.
3
Radboud University Medical Center, Nijmegen, The Netherlands.
PMID:
33310106
PMCID:
PMC7836616
DOI:
10.1016/j.ijid.2020.12.010
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Drug Treatment*
Chloroquine / adverse effects
Humans
Hydroxychloroquine* / adverse effects
Intensive Care Units
SARS-CoV-2
Substances
Hydroxychloroquine
Chloroquine